Ipca Laboratories gets VAI classification for Piparia manufacturing facility

24 Aug 2023 Evaluate

Ipca Laboratories’ Piparia (Silvassa) formulations manufacturing facility has received Voluntary Action Indicated (VAI) classification from U.S. Food and Drug Administration (USFDA). Based on this inspection, this facility is considered to be in a minimally acceptable state of compliance with regards to current good manufacturing practice (CGMP). 
USFDA had conducted inspection at the said manufacturing facility from April 18, 2023 to April 26, 2023, which inspection resulted into 3 observations under USFDA Form 483. 

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations.

Ipca Laboratories Share Price

1463.05 -22.55 (-1.52%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×